4//SEC Filing
Duarte Ira 4
Accession 0000950170-25-102158
CIK 0000818033other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 5:27 PM ET
Size
7.4 KB
Accession
0000950170-25-102158
Insider Transaction Report
Form 4
Duarte Ira
EVP, Chief Financial Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-07-31−11,695→ 163,721 totalExercise: $0.00→ Common Stock (11,695 underlying) - Exercise/Conversion
Common Stock
2025-07-31+11,695→ 164,218 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]The number of restricted stock units disclosed on the Reporting Person's Form 4 filed on April 22, 2025, May 2, 2025 and June 17 , 2025 ("Affected Form 4 Filings") were erroneously disclosed as an acquisition in Column 5(A) when it should have been disclosed as a disposition in Column 5(D). All other information in the Affected Form 4 Filings is correct.
- [F3]The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).
Documents
Issuer
HERON THERAPEUTICS, INC. /DE/
CIK 0000818033
Entity typeother
Related Parties
1- filerCIK 0001488864
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 5:27 PM ET
- Size
- 7.4 KB